Interim Results of Expanded Access for Deltarex-G for an Intermediate Size Population with Advanced Pancreatic Cancer and Sarcoma (NCT04091295) and Single Patient Use INDS for Early Stage Triple Receptor Positive, and Triple Receptor Negative Breast Cancer (IND# 19130)-MedSci.cn

Interim Results of Expanded Access for Deltarex-G for an Intermediate Size Population with Advanced Pancreatic Cancer and Sarcoma (NCT04091295) and Single Patient Use INDS for Early Stage Triple Receptor Positive, and Triple Receptor Negative Breast Cancer (IND# 19130)

Gordon, EM; Chawla, SP; Wong, S; Quon, D; Moradkhani, A; Reed, R; Brigham, DA; Swaney, WP; Hall, FL

MOLECULAR THERAPY, 2022; 30 (4): 514

科室
- - 订阅+
  - 更多科室
工具
服务